Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPARP: Olaparib in Advanced Castration-Resistant Prostate Cancer
2011-000601-49Phase 2Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of olaparib in prostate cancer (PCa), sponsored by The Institute of Cancer Research. Primary endpoint: Response rate. Status: unknown.
02
Drugs
olaparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-000601-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000601-49.